Anzeige
Mehr »
Login
Mittwoch, 16.04.2025 Börsentäglich über 12.000 News von 690 internationalen Medien
Global Tactical tritt dem Critical Minerals Institute bei!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QCUH | ISIN: SE0014855029 | Ticker-Symbol: 8IM1
Tradegate
15.04.25
14:31 Uhr
2,415 Euro
-0,030
-1,23 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IMPLANTICA AG SDR Chart 1 Jahr
5-Tage-Chart
IMPLANTICA AG SDR 5-Tage-Chart
RealtimeGeldBriefZeit
2,3902,43015.04.
2,3902,43515.04.

Aktuelle News zur IMPLANTICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiImplantica publishes Annual Report 2024160VADUZ, Liechtenstein, April 15, 2025 /PRNewswire/ -- Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report...
► Artikel lesen
DoImplantica announces a newly published real-world study from Germany reinforcing the excellent RefluxStop results331VADUZ, Liechtenstein, April 10, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
01.04.Implantica Sdr./1 Aktie: Wachstumsmotor startet durch.653Das Medizintechnikunternehmen aus Liechtenstein erweitert sein Exzellenzzentrum-Netzwerk und macht signifikante Schritte zur US-Markteinführung seiner GERD-Therapie. Implantica AG, ein in Liechtenstein...
► Artikel lesen
25.03.Implantica's RefluxStop garners strong interest at SAGES296VADUZ, Liechtenstein, March 25, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
19.03.Implantica Sdr./1 Aktie: Schwerpunkte der Wachstumspolitik271Das Medizintechnikunternehmen erhält positive FDA-Rückmeldung für sein RefluxStop-Implantat und wird in den STOXX Nordic Total Market Index aufgenommen. Die in Liechtenstein ansässige Medizintechnikfirma...
► Artikel lesen
IMPLANTICA Aktie jetzt für 0€ handeln
19.03.Implantica announces further expansion of RefluxStop centers of excellence and patient access in Spain330VADUZ, Liechtenstein, March 19, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
14.02.Implantica publishes Year-end Report, January - December 2024 (Q4)320VADUZ, Liechtenstein, Feb. 14, 2025 /PRNewswire/ -- RefluxStop FDA Milestone Significant events in the fourth quarter Submitted extensive clinical Module 2 of the 3 module-process...
► Artikel lesen
13.02.Implantica announces positive feedback received from U.S. FDA of the RefluxStop PMA Module 2 submission320VADUZ, Liechtenstein, Feb. 13, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop...
► Artikel lesen
12.02.Implantica announces Module 1 is accepted and closed by FDA in the PMA application for RefluxStop1.565VADUZ, Liechtenstein, Feb. 12, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device RefluxStop...
► Artikel lesen
07.02.Implantica presents the Year-end Report (Q4 2024) on February 14 at 15:00 CET296VADUZ, Liechtenstein, Feb. 7, 2025 /PRNewswire/ -- Implantica AG (publ) invites investors to a presentation of the Year-end Report (Q4 2024) at 15:00 CET on February 14. The Year-end Report...
► Artikel lesen
06.02.Implantica announces onboarding of the world-leading La Paz University Hospital, Spain210VADUZ, Liechtenstein, Feb. 6, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
04.02.Implantica announces completion of first GI-focused RefluxStop educational meeting by a prestigious NHS Hospital in the UK240VADUZ, Liechtenstein, Feb. 4, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
09.01.Implantica announces new exceptional published data from the largest real-world study from Germany454VADUZ, Liechtenstein, Jan. 9, 2025 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
23.12.24Implantica announces the payment of share rewards based on the AGM approved share-based incentive program as a directed share issue of own shares of the company without consideration12
23.12.24Implantica to be included in Nasdaq's First North 25 index551VADUZ, Liechtenstein, Dec. 23, 2024 /PRNewswire/ -- Implantica AG (publ), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
19.12.24Implantica strengthens the strategic RefluxStop expansion with the addition of yet another key University Hospital in Germany with several more in the pipeline444VADUZ, Liechtenstein, Dec. 19, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
18.12.24Implantica announces two new RefluxStop University Hospitals in Spain, leading to 10 active centers and many more to join soon399VADUZ, Liechtenstein, Dec. 18, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
17.12.24Implantica deepens market penetration in Italy with the addition of the ninth RefluxStop Center of Excellence and several lined up to start near-term530VADUZ, Liechtenstein, Dec. 17, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
15.11.24Implantica publishes Interim Report January - September 2024 (Q3)493VADUZ, Liechtenstein, Nov. 15, 2024 /PRNewswire/ -- RefluxStop achieves crucial FDA milestone and leaps forward with strong momentum in both the US and Europe Significant events in the...
► Artikel lesen
14.11.24Implantica submits FDA PMA application Clinical Module 2 for RefluxStop for U.S. market approval417VADUZ, Liechtenstein, Nov. 14, 2024 /PRNewswire/ -- Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the unique device...
► Artikel lesen
Seite:  Weiter >>
44 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1